De Beers Impairment & Diamond WeaknessA large impairment and negative EBITDA at De Beers reflect structural softness in rough-diamond demand and competitive disruption (lab‑grown, supply shifts). This reduces realizable exit value, complicates portfolio simplification and may force contingent/structured sale terms, limiting near-term proceeds and certainty.
Rising Leverage And Profitability PressureLeverage has nearly doubled since 2021 while the company has swung to net losses, weakening balance-sheet flexibility. Higher debt ratios reduce room for cyclical shocks, constrain optionality for large investments or M&A, and increase sensitivity to commodity downturns over the medium term.
Merger Regulatory & Execution RiskThe Anglo‑Teck merger is transformational and tied to a $4.5bn special dividend; outstanding approvals (China, South Korea) create execution risk. Delays or conditions could postpone strategic benefits, integration efficiencies and planned cash distributions, altering the company's medium-term capital plan.